Sandra Levy
ARTICLES BY THIS AUTHOR
- 8/20/2020
Stop & Shop kicks off flu shot availability
Flu shots are now available at Stop & Shop’s more than 250 pharmacy locations across the Northeast. - 8/20/2020
Ascend Labs’ generic Jadenu Sprinkle obtains FDA approval
Ascend has started shipping its generic Jadenu Sprinkle, which is indicated for patients with iron overload, and announced several staff additions. - 8/20/2020
Kroger Health expands COVID-19 testing at clinic locations
Kroger now offers COVID-19 testing by appointment across nine states. - 8/19/2020
Mark Panzer departs Albertsons
Mark Panzer, most recently Albertsons' senior vice president of pharmacy, health and wellness, is departing the company to pursue other interests, a company spokesperson said. - 8/19/2020
AstraZeneca obtains FDA green light for Breztri Aerosphere
AstraZeneca’s Breztri Aerosphere offers a maintenance treatment for those with chronic obstructive pulmonary disease. - 8/19/2020
OptimizeRx, Higi offering patients access to savings
OptimizeRx is partnering with Higi to provide consumers with access to savings and life sciences patient engagement programs. - 8/19/2020
CVS Health adds 77 drive-thru COVID-19 test sites in Florida
CVS Health expanded its COVID-19 testing program by deploying 77 additional test sites at select CVS Pharmacy drive-thru locations across Florida. - 8/18/2020
Mylan intros generic Tecfidera
Biogen’s Tecfidera is indicated for the treatment of relapsing forms of multiple sclerosis and is the first generic of any MS treatment in an oral solid dosage form. - 8/18/2020
Pharmacy orgs applaud HHS expanding pharmacists’ role in childhood vaccine access
The National Association of Chain Drug Stores, the American Pharmacists Association, and the National Community Pharmacists Association praised the Department of Health and Human Services for taking action to increase pharmacists’ role in providing childhood vaccinations. - 8/17/2020
Novartis wins patent protection for Gilenya
A Delaware district court has decided that HEC Pharm's generic fingolimod will infringe the dosage regimen patent for Novartis' Gilenya.
